We know Fibromyalgia is a multi-factorial disorder and most of these patients have genetic predisposition, high levels of neuroinflammation, and a hypersensitive pain transmission system. Moreover, many patients have endocrine insufficiency and deficiency in cellular energy. With over 25 years of experience in Personalized Medicine, Dr. Sahar Swidan, PharmD discussed this challenging topic and innovative treatment strategies.



Download Slides